Metabolically Healthy Obesity
8
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Gut, Immune, and Vascular Health in Metabolically Healthy Obesity
Breath Mass Spectrometry in Metabolic Syndrome and Metabolically Healthy Obesity
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
Small Extracellular Vesicles and Insulin Action
Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
Healthy vs Unhealthy Obesity: Mehanistic Insights and Effects of Time-Restricted Eating
Brown Fat Tissue Related Hormone Levels in Metabolically Healthy and Unhealthy Obese Individuals
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Obesity